Fresh analysis suggests that people who discontinue popular weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise programs.
Findings released in a leading health publication points out that while obese people frequently drop substantial amounts of their total mass while using the jabs, the mass returns at an average rate of 0.8 kg per month after stopping.
"Individuals buying these treatments must be aware of the danger of quick weight regain when the therapy is stopped," cautioned expert Dr. Susan Jebb.
Such speed of recovery means a return to original mass in about 18 months.
Comparing Approaches
The study, which looked at 37 of trials involving over 9,000 of patients, contrasted the results of these new drugs with other pills.
Researchers emphasize that individuals who shed pounds through diet and exercise typically experience a more gradual weight regain—around 0.1 kg a month—post-intervention.
Explaining the Rapid Regain
Nutrition scientists suggest the mechanism of the jabs accounts for the heightened rebound.
These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing GLP-1 levels several times higher than normal might result in the system to produce less of its own natural GLP-1, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication results in hunger is unsuppressed, making excessive eating much more probable."
An Ongoing Disease?
Medical guidelines advise the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
Many experts contend that, given the likelihood of weight regain, the therapy might need to be long-term.
This perspective is echoed by pharmaceutical companies, who note that the findings "underscore the persistent character of obesity," comparing it to managing diseases like hypertension.
Patient Testimonies
People who have come off the medication report a sudden return of appetite.
"It was like something that goes on and I was suddenly starving," described a patient.
The struggle is compounded if individuals have not adopted permanent dietary or behavioural changes during therapy.
Significant Interest
Survey data show that millions of adults in the UK have tried these injections in the past year, with desire being substantial.
- Adoption is higher among females than males.
- The 40s and 50s age group shows the highest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while these medications are potent tools for shedding pounds, they are not a standalone solution and long-term success likely depends on combined lifestyle management.
